DAX24.038 -0,8%ESt505.378 -0,7%Top 10 Crypto14,30 -1,4%Dow42.099 -0,6%Nas19.101 -0,5%Bitcoin95.770 -0,2%Euro1,1242 -0,5%Öl65,92 +1,5%Gold3.269 -0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 HENSOLDT HAG000 Tesla A1CX3T BYD A0M4W9 Siemens Energy ENER6Y Lufthansa 823212 D-Wave Quantum A3DSV9 thyssenkrupp 750000 Deutsche Bank 514000 Bayer BAY001 BASF BASF11 Commerzbank CBK100 Daimler Truck DTR0CK
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach NVIDIA-Zahlen: Asiens Börsen freundlich -- NVIDIA übertrifft Erwartungen -- Salesforce verdient mehr als erwartet -- GSK, Bilfinger im Fokus
Top News
Musk zieht sich aus Washington zurück Musk zieht sich aus Washington zurück
Heidelberg Materials-Aktie schwächer: Großaktionär Spohn verkauft Aktien Heidelberg Materials-Aktie schwächer: Großaktionär Spohn verkauft Aktien
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Illumina Aktie

Handeln
Illumina Aktien-Sparplan
74,72 EUR +3,62 EUR +5,09 %
FSE
84,50 USD +0,06 USD +0,07 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.11,61 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN927079

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4523271090

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolILMN

Illumina Aktien News

DatumMeistgelesen
PR NewswireIllumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireIllumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
Wer­bungIllumina-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireIllumina Reports Financial Results for First Quarter of Fiscal Year 2025
PR NewswireIllumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
PR NewswireIllumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
PR NewswireIllumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025
PR NewswireIllumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
PR NewswireAlliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
PR NewswireIllumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
PR NewswireIllumina transforms multiomic research with new technologies to unlock deeper understanding of biology
PR NewswireIllumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
PR NewswireIllumina unveils first-of-its-kind spatial transcriptomics technology
PR NewswireIllumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
PR NewswireIllumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025
PR NewswireIllumina and NVIDIA collaborate to decode biology and propel precision health
PR NewswireIllumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples
PR NewswireIllumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025
PR NewswireIllumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
PR NewswireMacrogen Consortium win tender for National Bio Big Data Project
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireSynaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
PR NewswireSynaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
PR NewswireIllumina announces expansion of TruSight Oncology portfolio
PR NewswireIllumina To Webcast Upcoming Investor Conferences
PR NewswireIllumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting
PR NewswireIllumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
PR NewswireIllumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
PR NewswireIllumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024
PR NewswireCharles Dadswell to step down as General Counsel, Illumina initiates search for successor
PR NewswireIllumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
PR NewswireResults of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
PR NewswireFDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
PR NewswireIllumina announces strategy to accelerate value creation
PR NewswireIllumina launches new oncology menu for NovaSeq X Series customers
PR NewswireIllumina to Present Upcoming Strategy Update
PR NewswireIllumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
PR NewswireIllumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base
PR NewswireIllumina completes the divestiture of GRAIL
PR NewswireIllumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
Wer­bung

Illumina News

Illumina News: auf dieser Seite finden Sie alle Illumina News und Nachrichten zur Illumina Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Illumina News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Illumina News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.